Globus Medical, Inc.: An Analysis Of Its International Market Expansion 

Globus Medical reported robust financial performance in its third quarter of 2024, signaling strong growth and successful integration following its merger with NuVasive. The company reported sales of $625.7 million, representing a significant growth of 63% from the previous year. This was due in large part to the added contributions from the NuVasive acquisition, reflecting the initial success of the merger. Noteworthy is the record free cash flow of $161.7 million, which matches the total free cash flow produced for the entire year of 2023. This surge in free cash flow is attributed to synergy capture and improved management of accounts receivable, demonstrating effective financial discipline post-merger.